Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > To all, whats your realistic price target after next PR? Thx

<< Previous

Bullboard Posts

Next >>

Comment by Maxmoeon Feb 15, 2021 9:25pm

190 Views

Post# 32570429

RE:To all, whats your realistic price target after next PR? Thx

I'll be the party pooper. There will be no press release tomorrow and the stock will trade down to 45. Friday morning, the press release will be ok. Just ok. No definitive eureka press release. Maybe a small private placement at 40 announced and sold out quickly. Stock stuck in the forties until, unless, a eureka moment at next press release in March. I'd call this worst case scenario in a bull market. All bets are off in a bear market , ie dow drops 10% or more.